Correlation Between Tarsus Pharmaceuticals and Morgan Stanley
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Morgan Stanley Direct, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Morgan Stanley.
Diversification Opportunities for Tarsus Pharmaceuticals and Morgan Stanley
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Tarsus and Morgan is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Morgan Stanley Direct in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley Direct and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley Direct has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Morgan Stanley go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Morgan Stanley
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to under-perform the Morgan Stanley. In addition to that, Tarsus Pharmaceuticals is 3.81 times more volatile than Morgan Stanley Direct. It trades about -0.02 of its total potential returns per unit of risk. Morgan Stanley Direct is currently generating about -0.01 per unit of volatility. If you would invest 2,083 in Morgan Stanley Direct on December 28, 2024 and sell it today you would lose (18.00) from holding Morgan Stanley Direct or give up 0.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Tarsus Pharmaceuticals vs. Morgan Stanley Direct
Performance |
Timeline |
Tarsus Pharmaceuticals |
Morgan Stanley Direct |
Tarsus Pharmaceuticals and Morgan Stanley Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tarsus Pharmaceuticals and Morgan Stanley
The main advantage of trading using opposite Tarsus Pharmaceuticals and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Morgan Stanley vs. NETGEAR | Morgan Stanley vs. Jerash Holdings | Morgan Stanley vs. AYRO Inc | Morgan Stanley vs. Mediaco Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |